Biomoda Granted Patent in Japan  
7/6/2011 11:03:29 AM

ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Cancer diagnostics company Biomoda, Inc. (OTCBB:BMOD) ( received notification that the Japan Patent Office has granted the company’s patent application related to a method of using its proprietary porphyrin-based compound that binds to cancer cells and causes them to fluoresce under specific frequencies of light to detect cancer and pre-cancerous cells in body fluid and tissue samples.